JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (5): 110-114.doi: 10.6040/j.issn.1673-3770.0.2016.322

Previous Articles     Next Articles

Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique.

XU Yuanteng1, CHEN Ruiqing2, LIN Gongbiao1, FANG Xiuling1, YU Shujuan1, LIANG Xiaohua3, ZHANG Rong   

  1. 1. Department of Otolaryngology;2. Central Laboratory;3. Clinical Laboratory, The First Affliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China
  • Received:2016-07-20 Online:2016-10-20 Published:2016-10-20

PDF (PC)

874

Abstract: Objective To study the effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. Methods Specific shRNA plasmid and negative control plasmid of PDCD4 gene were designed and synthesized. Hep-2 cells were transfected with shRNA plasmid and negative control plasmid. Real-time RT-PCR and Western blotting analysis were performed to determine the expressions of PDCD4 and β-catenin mRNA and protein after transfection, respectively. The proliferation of Hep-2 cells was observed by colony-forming assay. Results Compared to the control group, the colony formation rate of Hep-2 cells was significantly increased in the shRNNA plasmid group(P=0.01); the expressions of PDCD4 mRNA and protein were significantly reduced(P<0.01);the expressions of β-catenin mRNA and protein were significantly increased(P<0.01). Conclusion RNA interference technique can effectively silence PDCD4 gene expression of Hep-2 cells,enhance the colony forming ability of Hep-2 and increase the expressions of β-catenin mRNA and protein.

Key words: Hep-2 cell, PDCD4 gene, β-catenin, Cell proliferation, Laryngeal cancer, RNA interference

CLC Number: 

  • R739.65
[1] Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
[2] Shangina O, Brennan P, Szeszenia-Dabrowska N, et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe[J]. Am J Epidemiol, 2006, 164(4): 367-375.
[3] Gao X, Fisher S G, Mohideen N, et al. Second primary cancers in patients with laryngeal cancer: a population-based study[J]. Int J Radiat Oncol Biol Phys, 2003, 56(2): 427-435.
[4] Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinion in diagnosis and treatment of laryngeal carcinoma[J]. Cancer Treat Rev, 2006, 32(7): 504-515.
[5] Wang Q, Zhu J, Zhang Y, et al. Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice[J]. Eur J Cancer, 2013, 49(7): 1761-70.
[6] 冯国飞, 李培华, 尤慧华, 等. 喉癌组织中程序性细胞死亡因子4的表达及临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2011, 25(1): 16-19. FENG Guofei, LI Peihua, YOU Huihua, et al. The expression and clinical pathological significance of PDCD in laryngocarcinoma[J]. J Clin Otorhinolaryngol Head Neck Surgery, 2011, 25(1): 16-19.
[7] Shibahara K, Asano M, Ishida Y, et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death[J]. Gene, 1995, 166(2): 297-301.
[8] Wedeken L, Ohnheiser J, Hirschi B, et al. Association of Tumor Suppressor Protein Pdcd4 With Ribosomes Is Mediated by Protein-Protein and Protein-RNA Interactions[J]. Genes Cancer, 2010, 1(3): 293-301.
[9] Wen Y H, Shi X, Chiriboga L, et al. Alterations in the expression of PDCD4 in ductal carcinoma of the breast[J]. Oncol Rep, 2007, 18(6): 1387-1393.
[10] Zhang H, Ozaki I, Mizuta T, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma[J]. Oncogene, 2006, 25(45): 6101-6112.
[11] Chen Y, Kn(¨overo)sel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis[J]. J Pathol, 2003, 200(5): 640-646.
[12] 纪旭, 李虹, 符静, 等. PDCD4在喉癌中的表达及意义[J]. 解剖科学进展, 2014, 20(3): 273-275. JI Xu, LI Hong, FU Jing, et al. Expression and significance of PDCD4 in human laryngeal squamous cell carcinoma[J]. Prog Anat Sci, 2014, 20(3):273-275.
[13] Mudduluru G, Medved F, Grobholz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer[J]. Cancer, 2007, 110(8): 1697-1707.
[14] Wang Q, Sun Z, Yang H S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells[J]. Oncogene, 2008, 27(11): 1527-1535.
[15] 于锋, 黄鑫, 林颖, 等. siRNA下调β-catenin基因对喉癌Hep-2细胞增殖、凋亡和侵袭的影响[J]. 中国耳鼻咽喉头颈外科,2015,22(7): 329-333. YU Feng, HUANG Xin, LIN Ying, et al. Effect of siRNA downregulation of β-catenin on proliferation, apoptosis and invasion of laryngeal carcinoma Hep-2 cells[J]. Chin Arch Otolaryngol Head Neck Surgery, 2015,22(7): 329-333.
[16] Macdonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Developmental Cell, 2009, 17(1):9-26.
[17] Wang Q, Sun Z X, Allgayer H, et al. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells[J]. Oncogene, 2010, 29(1):128-138.
[18] Pietruszewska W, Kobos J, Gryczyński M. [Expression of beta-catenin protein in laryngeal squamous-cell carcinoma].[J]. Otolaryngologia Polska Polish Otolaryngol, 2004, 58(5):949-956.
[1] XIAO Junhua, PAN Qingchun, JIN Shu. Trend and projection of larynx cancer mortality caused by occupational exposure to sulfuric acid [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 55-61.
[2] XIE Feng, XU Zhenju, WU Ce, LIU Jie, ZANG Chuanshan, ZHANG Longxiao, HAN Min. Clinicopathologic and survival analysis of laryngeal neuroendocrine neoplasm in 26 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 79-86.
[3] QU Xiangyu, ZHU Han, LIU Zhonglu, MU Yakui, GUO Wentao, ZHANG Hua. Application of epiglottic tongue flap in supraglottic defect repair of laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 77-84.
[4] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[5] ZHANG Zhuping, YE Qi, GUO Bei, LIN Ling. Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 50-53.
[6] ZHANG Xi, DENG Qicheng, ZHANG Zhen, CHEN Yao, WANG Jingsong, ZHAO Rui, LIU Hai. Effect of nutritional support on postoperative pharyngeal fistula after laryngeal cancer surgery: a Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 51-59.
[7] XU Chong, WANG Xiaoting, YI Hongliang. Single-cell sequencing analysis of laryngeal cancer and its microenvironmental metabolism-related target genes [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 33-38.
[8] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[9] YAN Fancheng, JIANG Xian, CHAI Yijie, WANG Haosen, MENG Zhaoyang, WANG Xiaolei, WANG Yanling,. miR-30-5p inhibits retinoblastoma cell proliferation by downregulating FOXG1 expression [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 63-69.
[10] WANG MeiOverview,LI ZhihaiGuidance. Laryngeal cancer stem cells: potential therapeutic targets for overcoming multidrug resistance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 120-128.
[11] WANG Xiaoting, CHEN Zhengnong, YI Hongliang. Transcriptomic analysis of glutamine deprivation on laryngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 26-31.
[12] LI Yanjie, JIA Jian, YANG Ping, WAN Baoluo. Study on the value of tumor abnormal protein in clinical diagnosis of laryngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 70-74.
[13] LI Wenjing,LIU Ming. Research progress on the relationship between the C2H2 zinc finger protein family and laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 125-130.
[14] . The swallowing function recovery study on tongue flap after horizontal hemilaryngectomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 127-131.
[15] LI Guobin, ZHANG Zhancheng, WANG Xinyan. Up-regulation of miR-200b may inhibit epithelial mesenchymal transition process to prevent the proliferation, migration, and invasion of human laryngeal cancer Hep-2 cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 53-57.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd